Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07117136 · ClinicalTrials.gov registry record

Blinatumomab Consolidation in Real World

A clinical trial of B-Cell Acute Lymphoblastic Leukaemia, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT07117136: Recruiting study of B-Cell Acute Lymphoblastic Leukaemia, sponsored by Medical College of Wisconsin.

NCT07117136 is a study of B-Cell Acute Lymphoblastic Leukaemia that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07117136, a study of B-Cell Acute Lymphoblastic Leukaemia, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.

Primary Outcome

Complete remission as defined by patients having no lymphoblasts in the marrow or blood

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-08-28
Est. Completion 2029-05-14
Medical College of Wisconsin

447 total trials

What NCT07117136 shows while recruiting

NCT07117136 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with B-Cell Acute Lymphoblastic Leukaemia appearing as the primary indexed condition, and to 0 interventions.

NCT07117136 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT07117136 about?

NCT07117136 is a clinical study titled "Blinatumomab Consolidation in Real World". This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.

What is the current status of trial NCT07117136?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-08-28. Estimated completion is 2029-05-14.

What conditions does trial NCT07117136 study?

This clinical trial studies the following conditions: B-Cell Acute Lymphoblastic Leukaemia.

Who is sponsoring clinical trial NCT07117136?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07117136 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for B-Cell Acute Lymphoblastic Leukaemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07117136, the US trial registry maintained by the National Library of Medicine. NCT07117136 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.